Abstract
The APOBEC family members are involved in diverse biological functions. APOBEC3G restricts the replication of human immunodeficiency virus (HIV), hepatitis B virus and retroelements by cytidine deamination on single-stranded DNA or by RNA binding1,2,3,4. Here we report the high-resolution crystal structure of the carboxy-terminal deaminase domain of APOBEC3G (APOBEC3G-CD2) purified from Escherichia coli. The APOBEC3G-CD2 structure has a five-stranded β-sheet core that is common to all known deaminase structures and closely resembles the structure of another APOBEC protein, APOBEC2 (ref. 5). A comparison of APOBEC3G-CD2 with other deaminase structures shows a structural conservation of the active-site loops that are directly involved in substrate binding. In the X-ray structure, these APOBEC3G active-site loops form a continuous ‘substrate groove’ around the active centre. The orientation of this putative substrate groove differs markedly (by 90 degrees) from the groove predicted by the NMR structure6. We have introduced mutations around the groove, and have identified residues involved in substrate specificity, single-stranded DNA binding and deaminase activity. These results provide a basis for understanding the underlying mechanisms of substrate specificity for the APOBEC family.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.



References
Peled, J. U. et al. The biochemistry of somatic hypermutation. Annu. Rev. Immunol. 26, 481–511 (2008)
Goodman, M. F., Scharff, M. D. & Romesberg, F. E. AID-initiated purposeful mutations in immunoglobulin genes. Adv. Immunol. 94, 127–155 (2007)
Conticello, S. G., Langlois, M. A., Yang, Z. & Neuberger, M. S. DNA deamination in immunity: AID in the context of its APOBEC relatives. Adv. Immunol. 94, 37–73 (2007)
Chiu, Y. L. & Greene, W. C. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26, 317–353 (2008)
Prochnow, C., Bransteitter, R., Klein, M. G., Goodman, M. F. & Chen, X. S. The APOBEC-2 crystal structure and functional implications for the deaminase AID. Nature 445, 447–451 (2007)
Chen, K. M. et al. Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G. Nature 452, 116–119 (2008)
Chelico, L., Pham, P., Calabrese, P. & Goodman, M. F. APOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA. Nature Struct. Mol. Biol. 13, 392–399 (2006)
Chelico, L., Sacho, E. J., Erie, D. A. & Goodman, M. F. A model for oligomeric regulation of APOBEC3G cytosine deaminase-dependent restriction of HIV. J. Biol. Chem. 283, 13780–13791 (2008)
Chen, K. M. et al. Extensive mutagenesis experiments corroborate a structural model for the DNA deaminase domain of APOBEC3G. FEBS Lett. 581, 4761–4766 (2007)
Chung, S. J., Fromme, J. C. & Verdine, G. L. Structure of human cytidine deaminase bound to a potent inhibitor. J. Med. Chem. 48, 658–660 (2005)
Losey, H. C., Ruthenburg, A. J. & Verdine, G. L. Crystal structure of Staphylococcus aureus tRNA adenosine deaminase TadA in complex with RNA. Nature Struct. Mol. Biol. 13, 153–159 (2006)
Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997)
Schneider, T. R. & Sheldrick, G. M. Substructure solution with SHELXD. Acta Crystallogr. D 58, 1772–1779 (2002)
DeLano, W. L. The PyMOL Molecular Graphics System (DeLano Scientific, 2002)
Bertram, J. G., Bloom, L. B., O’Donnell, M. & Goodman, M. F. Increased dNTP binding affinity reveals a nonprocessive role for Escherichia coli β clamp with DNA polymerase IV. J. Biol. Chem. 279, 33047–33050 (2004)
Acknowledgements
We thank the staff at the Berkeley Laboratory’s Advanced Light Source (ALS) BL8.2.1 and Advanced Photon Source 19ID in Argonne National Laboratory for assistance in data collection, and M. Klein and other members of the X.S.C. laboratory for help and discussion. This work is supported in part by CBM graduate training grants to L.G.H. and Y.P.C., and by National Institutes of Health grants to M.F.G. and X.S.C.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Information
This file contains Supplementary Table 1, Supplementary Figures 1-3 with Legends and Supplementary Notes (PDF 348 kb)
Rights and permissions
About this article
Cite this article
Holden, L., Prochnow, C., Chang, Y. et al. Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications. Nature 456, 121–124 (2008). https://doi.org/10.1038/nature07357
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature07357
Further reading
-
Inhibition of base editors with anti-deaminases derived from viruses
Nature Communications (2022)
-
sgBE: a structure-guided design of sgRNA architecture specifies base editing window and enables simultaneous conversion of cytosine and adenosine
Genome Biology (2020)
-
Precise base editing with CC context-specificity using engineered human APOBEC3G-nCas9 fusions
BMC Biology (2020)
-
Understanding the structural basis of HIV-1 restriction by the full length double-domain APOBEC3G
Nature Communications (2020)
-
A rationally engineered cytosine base editor retains high on-target activity while reducing both DNA and RNA off-target effects
Nature Methods (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.